NCT05039788

Brief Summary

The working hypothesis is that hypertension during the first post-transplant trimester is partly explained by the patient's hypervolemia. The main objective of the single-center observational study "HTA ô Connect" is to study the relationship between hypertension and extracellular hyperhydration, thanks to repeated self-measurements of blood pressure and impedancemetry between the 30th and the 90th day post-transplant, in 150 incident kidney transplant patients from our department, the ITUN (Institute of Urology-Nephrology Transplantation). The study population involves 150 incident kidney transplant patients, presenting to the Nantes University Hospital Transplant Institute for 1 month (D30), and presenting with hypertension ≥ 140/90mmHg and not treated with a diuretic. Data collected at the patients' homes will be used to establish a relationship between blood pressure and extracellular water volume. The data collected will not be used to follow up patients who participated in the study in this first stage of exploration.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Oct 2021Aug 2026

First Submitted

Initial submission to the registry

June 8, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 10, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 14, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2025

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2026

Expected
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

June 8, 2021

Last Update Submit

April 14, 2026

Conditions

Keywords

HypertensionHypervolemiaSelf-measurementConnected

Outcome Measures

Primary Outcomes (2)

  • Correlation between Hypertension and extracellular hyperhydration

    Hypertension will be assessed by measurement of blood pressure

    Day 90

  • Correlation between Hypertension and extracellular hyperhydration

    Extracellular hyperhydration will be measured by impedance measurement

    Day 90

Secondary Outcomes (10)

  • hypertension measurement

    For 3 month post-transplant

  • Impedance measurement

    For 3 month post-transplant

  • Weight measurement

    day 30

  • Weight measurement

    Day 90

  • Weight measurement

    3 days a week between the 30th and the 90th day after transplantation.

  • +5 more secondary outcomes

Interventions

Measurement of systolic and diastolic blood pressure, impedancemetry, weight, creatinemia and Pro-BNP measurements At D30 and D90 Measurement of systolic and diastolic blood pressure, impedancemetry, weight, 3 times a week between D30 and D90 post-transplant,

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population involves 150 incident kidney transplant patients, presenting to the Nantes University Hospital Transplant Institute for 1 month (D30), and presenting with hypertension ≥ 140/90mmHg recorded in the outpatient clinic at the Nantes University Hospital, according to the recommendations of the French Society of Arterial Hypertension (6) and not treated with a diuretic. There will be no emergency inclusion. Recently transplanted patients will come regularly, between 1 and 2 times per week, to the Nantes University Hospital during the first month. The study will be presented to them during this period and they will be included at the D30 (M1) consultation.

You may qualify if:

  • Age ≥ 18 years
  • Blood pressure ≥ 140/90mmHg on 3 occasions and according to the recommendations of the French Society of Hypertension (6) at the M1 consultation
  • Patients 1 to 6 months post-kidney transplant
  • Isolated kidney transplant patient
  • BMI between 16 and 34 kg/cm2
  • Not opposed to the research

You may not qualify if:

  • History of non-renal transplantation
  • Minors, adults under guardianship and protected persons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, Loire-Atlantique, 44093, France

RECRUITING

MeSH Terms

Conditions

HypertensionEdema

Interventions

Blood PressureWeights and Measures

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaInvestigative Techniques

Study Officials

  • Claire GARANDEAU, PH

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2021

First Posted

September 10, 2021

Study Start

October 14, 2021

Primary Completion

October 14, 2025

Study Completion (Estimated)

August 10, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations